Search research articles
Contact Us
Filters
Showing results (31-40 of 73) with videos related to
Page
of 8
Sort By:
International Journal of Cancer
|
June 7, 2007
Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145
Christopher P Leamon, Joseph A Reddy, Iontcho R Vlahov, et al.
Annals of the New York Academy of Sciences
|
October 3, 2009
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
Mini Thomas, Sumith A Kularatne, Longwu Qi, et al.
Cancer Research
|
December 3, 2008
Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue
Christopher P Leamon, Joseph A Reddy, Marilynn Vetzel, et al.
Nature Communications
|
June 20, 2019
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
Yong Gu Lee, Haiyan Chu, Yingjuan Lu, et al.
Journal of Clinical Pharmacology
|
October 20, 2009
Clinical pharmacokinetics and exposure-toxicity relationship of a folate-Vinca alkaloid conjugate EC145 in cancer patients
Jing Li, Edward A Sausville, Patrick J Klein, et al.
Bioconjugate Chemistry
|
November 21, 2002
Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical
Christopher P Leamon, Matthew A Parker, Iontcho R Vlahov, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2006
Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide
Iontcho R Vlahov, Hari Krishna R Santhapuram, Paul J Kleindl, et al.
American Journal of Physiology. Renal Physiology
|
May 3, 2018
Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease
Kevin R Kipp, Samantha L Kruger, Margaret F Schimmel, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 15, 2019
Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases
Barbara Frigerio, Claudia Bizzoni, Gerrit Jansen, et al.
Molecular Cancer Therapeutics
|
December 19, 2006
Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice
Yingjuan Lu, Le-Cun Xu, Nikki Parker, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 73) with videos related to
Sort By:
Page
of 8
International Journal of Cancer
|
June 7, 2007
Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145
Christopher P Leamon, Joseph A Reddy, Iontcho R Vlahov, et al.
Annals of the New York Academy of Sciences
|
October 3, 2009
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
Mini Thomas, Sumith A Kularatne, Longwu Qi, et al.
Cancer Research
|
December 3, 2008
Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue
Christopher P Leamon, Joseph A Reddy, Marilynn Vetzel, et al.
Nature Communications
|
June 20, 2019
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
Yong Gu Lee, Haiyan Chu, Yingjuan Lu, et al.
Journal of Clinical Pharmacology
|
October 20, 2009
Clinical pharmacokinetics and exposure-toxicity relationship of a folate-Vinca alkaloid conjugate EC145 in cancer patients
Jing Li, Edward A Sausville, Patrick J Klein, et al.
Bioconjugate Chemistry
|
November 21, 2002
Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical
Christopher P Leamon, Matthew A Parker, Iontcho R Vlahov, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2006
Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide
Iontcho R Vlahov, Hari Krishna R Santhapuram, Paul J Kleindl, et al.
American Journal of Physiology. Renal Physiology
|
May 3, 2018
Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease
Kevin R Kipp, Samantha L Kruger, Margaret F Schimmel, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 15, 2019
Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases
Barbara Frigerio, Claudia Bizzoni, Gerrit Jansen, et al.
Molecular Cancer Therapeutics
|
December 19, 2006
Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice
Yingjuan Lu, Le-Cun Xu, Nikki Parker, et al.
Page
of 8